Results 141 to 150 of about 285,431 (226)

Non-muscle myosin heavy chain IIA regulates cell morphology, stress fibre structure, and cell migration in FLO-1 oesophageal adenocarcinoma cells. [PDF]

Hum Cell
Duff D, Gargan S, Long A.
europepmc   +1 more source

Myeloid-Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID-19. [PDF]

J Med Virol
Lai C, Lu S, Yang Y, You X, Xu F, Deng X, Lan L, Guo Y, Kuang Z, Luo Y, Yuan L, Meng L, Wu X, Song Z, Jiang N.   +14 more
europepmc   +1 more source

HEAVY-CHAIN (FC FRAGMENT) DISEASE

, 1969
Takao Tsuji, Yasuyuki Ohta, Toshinari Kobayashi, H. Danjo, Kanya OKA, Y. Mizuno, Masami Sato, Tetsuichi Izawa, Hiroshi Miki, Kiyowo Kosaka, Masanobu Imai, Chizuko Miyamoto, Mamoru Hirohata   +12 more
openalex   +2 more sources

JSH practical guidelines for hematological malignancies, 2023: II. lymphoma-overview. [PDF]

Int J Hematol
Ohmachi K.
europepmc   +1 more source

Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states. [PDF]

Virus Res
Myers ML, Conlon MT, Gallagher JR, Woolfork DD, Khorrami ND, Park WB, Stradtman-Carvalho RK, Harris AK.   +7 more
europepmc   +1 more source

Neurofilament heavy chain in secondary progressive multiple sclerosis. [PDF]

Mult Scler
De Angelis F, Ammoscato F, Parker RA, Plantone D, Doshi A, John NA, Williams T, Stutters J, MacManus D, Schmierer K, Barkhof F, Weir CJ, Giovannoni G, Chataway J, Gnanapavan S.   +14 more
europepmc   +1 more source

Human heavy chain disease protein WIS: implications for the organization of immunoglobulin genes.

, 1979
E. C. Franklin, Frances Prelli, Blas Frangione   +2 more
openalex   +1 more source

Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan-Sarbecoviruses. [PDF]

MedComm (2020)
Qiao R, Liu Y, Mao Q, Li J, Lu Y, Shi J, Li C, Yu J, Gong J, Wang X, Shao Y, Sun L, Zhang W, Yu H, Chu H, Wang P, Zhao X.   +16 more
europepmc   +1 more source

Neurodegenerative and neuroinflammatory changes in SOD1-ALS patients receiving tofersen. [PDF]

Sci Rep
Simonini C, Zucchi E, Martinelli I, Gianferrari G, Lunetta C, Sorarù G, Trojsi F, Pepe R, Piras R, Giacchino M, Banchelli F, Mandrioli J.   +11 more
europepmc   +1 more source

Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A Review. [PDF]

JAMA Intern Med
Liu Y, Parks AL.
europepmc   +1 more source